切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2017, Vol. 11 ›› Issue (02) : 141 -145. doi: 10.3877/cma.j.issn.1674-1358.2017.02.008

临床论著

慢性乙型肝炎患者抗病毒治疗前高尔基体蛋白73与细胞因子的相关性
魏梅娟1, 张小曼1, 许正锯1,(), 肖子鸿1, 张纯瑜1, 何彩婷1   
  1. 1. 362000 泉州市,解放军第180医院南京军区肝病中心
  • 收稿日期:2016-02-22 出版日期:2017-04-15
  • 通信作者: 许正锯
  • 基金资助:
    军区医学科技创新经费资助项目(No. 14MS095)

Correlation of GP73 and cytokines before antiviral therapy in patients with chronic hepatitis B

Meijuan Wei1, Xiaoman Zhang1, Zhengju Xu1,(), Zihong Xiao1, Chunyu Zhang1, Caiting He1   

  1. 1. Live Diseases Center of Nanjing Military Command, 180 Hospital of PLA, Quanzhou 362000, China
  • Received:2016-02-22 Published:2017-04-15
  • Corresponding author: Zhengju Xu
引用本文:

魏梅娟, 张小曼, 许正锯, 肖子鸿, 张纯瑜, 何彩婷. 慢性乙型肝炎患者抗病毒治疗前高尔基体蛋白73与细胞因子的相关性[J/OL]. 中华实验和临床感染病杂志(电子版), 2017, 11(02): 141-145.

Meijuan Wei, Xiaoman Zhang, Zhengju Xu, Zihong Xiao, Chunyu Zhang, Caiting He. Correlation of GP73 and cytokines before antiviral therapy in patients with chronic hepatitis B[J/OL]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2017, 11(02): 141-145.

目的

研究慢性乙型肝炎患者干扰素治疗前,不同疗效组患者高尔基体蛋白73(GP73)与细胞因子的相关性,并分析GP73在慢性乙型肝炎的作用。

方法

收集113例慢性乙型肝炎(CHB)患者干扰素α抗病毒治疗前的血清,采用酶联免疫法检测血清中GP73与TNF-α、IFN-γ、IL-2、IL-10和IL-12等细胞因子的水平,采用Pearson法分析血清GP73与细胞因子的相关性。

结果

干扰素α治疗病毒学应答组患者血清中GP73、IL-2、IL-12、TNF-α和IFN-γ含量均较部分病毒学应答组患者高,差异具有统计学意义(P均< 0.05);无应答组患者血清中IL-2、TNF-α和IFN-γ的含量较部分病毒学应答组高,差异具有统计学意义(P均< 0.05);与无应答组对比,病毒学应答组患者仅IL-2和IL-10含量较高,差异具有统计学意义(P均< 0.05),两组患者其他指标差异无统计学意义。干扰素α治疗病毒学应答组患者中,治疗前血清GP73与TNF-α、IL-2、IL-12均呈正相关(r = 0.8045、P < 0.001,r = 0.5693、P < 0.001,r = 0.499、P = 0.001),而与IL-10、IFN-γ无相关性。干扰素α治疗部分病毒学应答组患者中,治疗前血清GP73仅与IL-12呈正相关(r = 0.4248、P = 0.0107),与其他细胞因子无相关性。干扰素α治疗无应答组患者中,治疗前血清GP73与细胞因子均无相关性。此外,病毒学应答组患者血清中GP73、IL-2、IL-12、TNF-α和IFN-γ含量均较部分病毒学应答组高,差异均具有统计学意义(P均< 0.05)。

结论

慢性乙型肝炎患者的血清GP73可能参与免疫调节过程。

Objective

To investigate the correlation of serum GP73 and cytokines in different therapeutic groups of patients with chronic hepatitis B before treated with interferon, and to analyze the role of GP73 in chronic hepatitis B.

Methods

Total of 113 patients with CHB were enrolled. Serum levels of GP73, TNF-α, IFN-γ, IL-2, IL-10 and IL-12 were detected by enzyme-linked immunosorbent assay before patients treated with IFN-α antiviral therapy. The correlations between serum GP73 and cytokines were analyzed by Pearson’s correlations method.

Results

The concentrations of serum GP73, IL-2, IL-12, TNF-α and IFN-γ in patients with complete response to IFN treatment were significantly higher than those in patients with partial response (all P < 0.05). The concentrations of serum IL-2, TNF-α and IFN-γ in patients with non-response to IFN treatment were also significantly higher than those in patients with partial response (all P < 0.05). However, there were no significant differences between patients with complete response and non-response except for IL-2 and IL-10 (P > 0.05). Moreover, there were significant positive correlations between serum GP73 and cytokines of TNF-α (r = 0.8045, P < 0.001), IL-2 (r = 0.5693, P < 0.001) and IL-12 (r = 0.499, P = 0.001) in patients with complete response to IFN treatment. And in patients with partial response, the correlation between serum GP73 and IL-12 (r = 0.4248, P = 0.0107) was significant, however, the correlation between serum GP73 and the other cytokines were not significant. The level of GP73 and cytokines in patients with non-response to IFN treatment were with no correlation.

Conclusions

GP73 in patients with CHB may participate in immune regulation.

表1 对照组与观察组患者抗病毒治疗前各指标水平
组别 例数 年龄(±s,岁) 男性[例(%)] GP73(±s,ng/ml) IL-2(±s,pg/ml) IL-10(±s,pg/ml)
对照组 50 27.85±4.58 40(80.00) 40.38±17.69 15.19±4.15 10.03±2.51
病毒学应答组 39 29.69±8.22 33(84.62) 130.6±58.35 106.90±32.55 27.10±7.59
部分病毒学应答组 35 28.00±2.65 28(80.00) 98.17±40.36 56.16±13.97 23.92±6.33
无应答组 39 26.69±6.50 30(76.92) 124.40±66.60 104.80±95.99 26.20±13.94
a统计量   q = 1.623 χ2 = 0.27 H = 2.525 H = 6.249 H = 1.628
aP   0.487 0.602 0.012 < 0.001 0.104
b统计量   q = 1.254 χ2 = 0.7429 H = 1.808 H = 2.877 H = 0.715
bP   0.65 0.743 0.071 0.004 0.475
c统计量   q = 2.958 χ2 = 0.1031 H = 0.737 H = 3.467 H = 2.408
cP   0.296 0.748 0.461 0.001 0.016
组别 例数 IL-12(±s,ng/ml) TNF-α(±s,pg/ml) IFN-γ(±s,pg/ml) HBV DNA(±s,log10拷贝/ml) ALT(±s,IU/L)
对照组 50 1.35±0.82 5.27±1.03 18.65±4.01 < 2.69 21.43±8.15
病毒学应答组 39 7.92±2.12 66.08±8.51 45.30±10.12 6.30±0.87 520.00±323.6
部分病毒学应答组 35 6.27±1.44 59.64±3.86 34.77±5.85 6.72±0.89 674.80±550.4
无应答组 39 8.31±6.11 71.22±29.04 45.51±24.29 6.64±0.84 394.50±325.6
a统计量   H = 2.983 H = 3.373 H = 4.76 q = 2.965 H = 0.973
aP   0.003 0.001 < 0.001 0.095 0.771
b统计量   H = 1.010 H =-2.217 H =-2.771 q = 0.530 H = 3.087
bP   0.313 0.027 0.006 0.926 0.079
c统计量   H = 2.029 H = 1.188 H = 2.045 q = 2.504 H = 2.173
cP   0.042 0.235 0.041 0.184 0.278
表2 血清GP73与IL-2的相关性(±s
表3 血清GP73与IL-10的相关性(±s
表4 血清GP73与IL-12的相关性(±s
表5 血清GP73与TNF-α的相关性(±s
表6 血清GP73与IFN-γ的相关性(±s
1
Kladney, RD, Bulla GA, Guo L, et al. GP73, a novel Golgi-localized protein upregulated by viral infection[J]. Gene,2000,249(1-2):53-65.
2
张勤,续薇. 高尔基体蛋白73与肝脏疾病关系的研究进展[J]. 国际检验医学杂志,2014,35(15): 2058-2060.
3
Kladney RD, Cui X, Bulla GA, et al. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease[J]. Hepatology,2002,35(6):1431-1440.
4
许正锯,潘兴南,魏开鹏, 等. 血清高尔基体蛋白73与慢性乙型肝炎病毒感染者肝脏炎症损伤的相关性[J/CD]. 中华实验和临床感染病杂志(电子版),2014,8(5):598-604.
5
Xu Z, Liu L, Pan X, et al. Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease[J]. Medicine(Baltimore),2015,94(12):e659.
6
Liang H, Block TM, Wang M, et al., Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73[J]. Cancer Biomark,2012,11(4):161-171.
7
中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2010年版)[J/CD]. 中国肝脏病杂志(电子版),2011,3(1):40-56.
8
吴群,刘小兵. 干扰素α-1b治疗慢性乙肝疗效10年随访[J]. 医学信息,2013,27(14):197-198.
9
Sadler AJ, Williams BR. Interferon-inducible antiviral effectors[J]. Nat Rev Immunol,2008,8(7):559-568.
10
Pham NL, Badovinac VP, Harty JT. Differential role of "ignal 3" inflammatory cytokines in regulating CD8 T cell expansion and differentiation in vivo[J]. Front Immunol,2011,2:4.
11
Crouse J, Kalinke U, Oxenius A. Regulation of antiviral T cell responses by type I interferons[J]. Nat Rev Immunol,2015,15(4):231-242.
12
Ramos HJ, Davis AM, George TC, et al. IFN-alpha is not sufficient to drive Th1 development due to lack of stable T-bet expression[J]. J Immunol,2007,179(6):3792-3803.
13
Isorce N, Lucifora J, Zoulim F, et al. Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies[J]. Antiviral Res,2015,122:69-81.
14
Tangkijvanich P, Komolmit P, Mahachai V, et al. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B[J]. J Clin Virol,2009,46(2):117-123.
15
Hansen BE, Buster EH, Steyerberg EW, et al.Prediction of the response to peg-interferon-alfa in patients with HBeAg positive chronic hepatitis B using decline of HBV DNA during treatment[J]. J Med Virol,2010,82(7):1135-1142.
16
占国清,谭华炳,谢杏榕, 等. α干扰素治疗HBeAg阳性慢性乙型肝炎疗效的预测指标[J]. 胃肠病学和肝病学杂志,2011,20(7):663-665.
17
Iftikhar R, Kladney RD, Havlioglu N, et al. Disease- and cell-specific expression of GP73 in human liver disease[J]. Am J Gastroenterol,2004,99(6):1087-1095.
18
Hu L, Yao W, Wang F, et al. GP73 is upregulated by hepatitis C virus (HCV) infection and enhances HCV secretion[J]. PLoS One,2014,9(3):e90553.
19
冯志刚,岑晓红,云俊木, 等. GP73在酒精性肝病中的临床意义[J]. 国际检验医学杂志,2015,36(15):2214-2215.
20
Wang F, Long Q, Gong Y, et al. Epithelium-Specific ETS (ESE)-1 upregulated GP73 expression in hepatocellular carcinoma cells[J]. Cell Biosci,2014,4(1):76-86.
[1] 钱雅君, 虞竹溪, 徐颖, 董丹江, 顾勤. 危重型新型冠状病毒感染合并侵袭性肺曲霉病的临床特征和高危因素分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(01): 3-9.
[2] 陈腊青, 林佳佳, 毛洪刚, 童冠海, 汪梦娜, 夏红波, 刘卓, 徐海霞, 赵玉华, 张传领. 血清细胞因子及呼出气一氧化氮在哮喘-慢性阻塞性肺疾病重叠综合征中的临床意义[J/OL]. 中华危重症医学杂志(电子版), 2023, 16(04): 316-320.
[3] 李永浩, 高雪菲, 郭田田, 张进, 张彩针, 刘静. 肥胖合并甲状腺癌相关机制的研究进展[J/OL]. 中华普通外科学文献(电子版), 2023, 17(04): 311-315.
[4] 张燕, 杨跃青, 邱峥. IgG 联合血清细胞因子对肺结核并发慢性肺曲霉菌病的诊断意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 809-812.
[5] 蒋丽芳, 林冰. 桑菊清解汤联合左氧氟沙星治疗社区获得性肺炎的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 458-461.
[6] 傅红兴, 王植楷, 谢贵林, 蔡娟娟, 杨威, 严盛. 间充质干细胞促进胰岛移植效果的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 351-360.
[7] 徐嘉愉, 张复华, 牛国敏, 梁家宝, 潘焕玉, 麦秀蕖, 杨国雷, 徐嘉良, 黄佑勇. Th1/Th2细胞因子谱在恶性血液肿瘤患者化疗后中性粒细胞缺乏伴感染的应用价值[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 143-150.
[8] 阿卜杜萨拉木·图尔荪麦麦提, 吐尔洪江·吐逊, 温浩. 肝脏缺血-再灌注损伤与cGAS-STING信号通路[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 394-397.
[9] 杨金涓, 夏建平. 糖尿病性黄斑水肿患者基线房水细胞因子水平评估血管内皮生长因子疗效的临床研究[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(06): 350-355.
[10] 杨智钧, 谷佳, 丁聿贤, 张正奎, 于如同. 脑胶质瘤患者血清炎性因子水平与病理分级及预后的相关性[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 238-242.
[11] 陈蕊, 杨洪娜, 方巍, 李鑫鑫, 李甜甜, 于孝义, 王艳雪, 李文玉. 血清与支气管肺泡灌洗液中细胞因子水平与肺内外ARDS的相关性研究[J/OL]. 中华重症医学电子杂志, 2023, 09(03): 251-258.
[12] 丛黎, 马林, 陈旭, 李文文, 张亮亮, 周华亭. 改良CT严重指数联合炎症指标在重症急性胰腺炎患者胰腺感染预测及预后评估中的研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 432-436.
[13] 刘立业, 赵德芳. 非酒精性脂肪肝患者血清细胞因子信号转导抑制因子3、肝X受体α水平与CT影像学特征的相关性[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(04): 211-215.
[14] 李益军, 梁兴森, 方细霞, 肖文良, 李湘, 高彦平, 李嘉, 李玲. 温针灸治疗早中期寒湿痹阻型膝骨关节炎的疗效观察[J/OL]. 中华针灸电子杂志, 2024, 13(01): 7-12.
[15] 南朝涛, 陈建, 王书鸿, 李刚, 郝俊杰. 血清细胞因子预测急性脑梗死后肺炎的价值[J/OL]. 中华卫生应急电子杂志, 2024, 10(01): 16-20.
阅读次数
全文


摘要